Vanguard Global Advisers
ATYR

Vanguard Global Advisers’s aTyr Pharma ATYR Stock Holding History

Vanguard Global Advisers’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.9K Hold
33,414
– – ﹤0.01% 3333
2026
Q1 		$26.1K Buy
+33,414
New +$28.2K ﹤0.01% 3241

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Global Advisers's ATYR Position: Q2 2026 in Review

Vanguard Global Advisers held its aTyr Pharma (ATYR) position steady in Q2 2026 at 33,414 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3333.

Vanguard Global Advisers first reported a position in ATYR in Q1 2026 and has held it in 2 quarters since. The position peaked at $26.1K in Q1 2026. 86 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Vanguard Global Advisers held 33,414 shares of aTyr Pharma worth $19.9K as of Q2 2026.
  • Vanguard Global Advisers left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3333 holding.
  • Vanguard Global Advisers first reported a position in aTyr Pharma in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's aTyr Pharma position peaked at $26.1K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.